DK2790710T3 - Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser - Google Patents
Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser Download PDFInfo
- Publication number
- DK2790710T3 DK2790710T3 DK12857932.3T DK12857932T DK2790710T3 DK 2790710 T3 DK2790710 T3 DK 2790710T3 DK 12857932 T DK12857932 T DK 12857932T DK 2790710 T3 DK2790710 T3 DK 2790710T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- bone disorders
- malabsorption
- metabolic bone
- calcium
- Prior art date
Links
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title 1
- 206010025476 Malabsorption Diseases 0.000 title 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 title 1
- 208000029725 Metabolic bone disease Diseases 0.000 title 1
- 229910052791 calcium Inorganic materials 0.000 title 1
- 239000011575 calcium Substances 0.000 title 1
- 229910000019 calcium carbonate Inorganic materials 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161569805P | 2011-12-13 | 2011-12-13 | |
| US201261680721P | 2012-08-08 | 2012-08-08 | |
| PCT/IL2012/050521 WO2013088440A1 (en) | 2011-12-13 | 2012-12-13 | Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2790710T3 true DK2790710T3 (da) | 2020-11-30 |
Family
ID=48611949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12857932.3T DK2790710T3 (da) | 2011-12-13 | 2012-12-13 | Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10064890B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2790710B1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP2015500333A (cg-RX-API-DMAC10.html) |
| CN (2) | CN104114179A (cg-RX-API-DMAC10.html) |
| AU (3) | AU2012354056B2 (cg-RX-API-DMAC10.html) |
| CA (2) | CA3056570C (cg-RX-API-DMAC10.html) |
| DK (1) | DK2790710T3 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2831699T3 (cg-RX-API-DMAC10.html) |
| IL (2) | IL233107B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013088440A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150374747A1 (en) * | 2013-02-11 | 2015-12-31 | Amorphical Ltd. | Amorphous calcium carbonate for accelerated bone growth |
| CA2956048C (en) | 2014-07-31 | 2023-01-24 | Amorphical Ltd. | Encapsulated amorphous calcium carbonate compositions |
| US12121538B2 (en) | 2015-06-04 | 2024-10-22 | Amorphical Ltd. | Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration |
| AU2016273058B2 (en) * | 2015-06-04 | 2021-05-20 | Amorphical Ltd. | Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates |
| JP2017032550A (ja) * | 2015-07-30 | 2017-02-09 | 大塚製薬株式会社 | 胃粘膜萎縮の有無を判定する方法 |
| US12629390B2 (en) | 2016-01-18 | 2026-05-19 | Amorphical Ltd. | Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions |
| AU2017210259B2 (en) | 2016-01-18 | 2022-11-03 | Amorphical Ltd. | Stabilized amorphous calcium carbonate as a supplement for cell culture media |
| US20230365935A1 (en) * | 2016-01-18 | 2023-11-16 | Amorphical Ltd. | Stabilized amorphous calcium carbonate as a supplement for cell culture media |
| KR102828392B1 (ko) | 2016-01-18 | 2025-07-02 | 아모피컬 리미티드 | 신경, 근육 및 불임 질환 또는 병증의 치료를 위한 안정화된 무정형 탄산칼슘 |
| JP6872680B2 (ja) * | 2016-03-22 | 2021-05-19 | 国立大学法人 宮崎大学 | カルシウム吸収促進剤 |
| IL266149B (en) * | 2016-10-25 | 2022-08-01 | Amorphical Ltd | Amorphous calcium carbonate for treating a leukemia |
| CN110123836A (zh) * | 2019-05-20 | 2019-08-16 | 昆明朗盛生物科技有限公司 | 钙锌维生素d泛酸片的应用 |
| MX2022000947A (es) | 2019-07-23 | 2022-04-26 | Amorphical Ltd | Carbonato de calcio amorfo para mejorar el rendimiento deportivo. |
| BR112022018055A2 (pt) * | 2020-03-11 | 2022-10-18 | Amorphical Ltd | Carbonato de cálcio amorfo para tratamento de acidose. |
| WO2021226064A1 (en) * | 2020-05-04 | 2021-11-11 | University Of Louisville Research Foundation, Inc. | Artificial intelligence-based systems and methods for dosing of pharmacologic agents |
| MX2023002801A (es) * | 2020-09-15 | 2023-04-21 | Oncoinvent As | Particulas radiomarcadas de tama?o controlado. |
| JP7573310B2 (ja) * | 2022-02-28 | 2024-10-25 | 一般社団法人 Unical | ヒトによる経口摂取のためのカルシウム組成物 |
| AU2023378960A1 (en) * | 2022-11-08 | 2025-06-12 | Amorphical Ltd. | Methods for preparing amorphous calcium carbonate by fixation of carbon dioxide |
| WO2026044304A1 (en) * | 2024-08-20 | 2026-02-26 | Clarke Black Kim Jean | A health supplement composition, and a method of manufacturing a health supplement composition |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0304987B1 (en) * | 1987-08-28 | 1992-11-11 | Norwich Eaton Pharmaceuticals, Inc. | Novel calcium supplements |
| CA1336328C (en) | 1988-04-11 | 1995-07-18 | Walter G. Leonard | Method of increasing bone density in humans |
| WO1997024069A1 (en) | 1995-12-26 | 1997-07-10 | Holomed Aps | A method and system for generating an x-ray image |
| JPH10236957A (ja) | 1997-02-24 | 1998-09-08 | Bankaku Souhonpo:Kk | 骨粗鬆症の改善剤 |
| SE9702401D0 (sv) * | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
| JP2003292453A (ja) | 2002-04-02 | 2003-10-15 | Asahi Kasei Corp | 骨疾患治療用医薬複合剤 |
| US7267832B2 (en) * | 2004-02-18 | 2007-09-11 | Kraft Foods Holdings, Inc. | Amorphous water-soluble calcium citrate salts and method of making and using same |
| ES2447747T3 (es) * | 2004-05-26 | 2014-03-12 | Ben Gurion University Of The Negev Research And Development Authority | Composiciones administrables por vía oral que comprenden carbonato cálcico amorfo estable |
| US20070041506A1 (en) | 2005-08-22 | 2007-02-22 | Michelle Bottino | Digital sensor holder |
| GB0522045D0 (en) | 2005-10-28 | 2005-12-07 | Novartis Ag | Pharmaceutical compositions |
| IL178495A (en) * | 2006-10-05 | 2014-12-31 | Univ Ben Gurion | Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions |
| US8802160B2 (en) * | 2007-10-22 | 2014-08-12 | Amorphical Ltd. | Stable amorphous calcium carbonate comprising phosphorylated amino acids |
| WO2009087553A1 (en) | 2008-01-02 | 2009-07-16 | Aurobindo Pharma Limited | Kits for administering bisphosphonates |
| CN101314031A (zh) | 2008-07-14 | 2008-12-03 | 王冰 | 一种改善骨营养的制剂 |
| WO2010045558A1 (en) * | 2008-10-17 | 2010-04-22 | Fresenius Medical Care Holdings, Inc. | Method of determining a phosphorus binder dosage for a dialysis patient |
| CN102085356B (zh) | 2010-12-28 | 2013-02-27 | 北京同仁堂健康药业股份有限公司 | 一种用于增加骨密度的组合物及其制备方法 |
-
2012
- 2012-12-13 JP JP2014546729A patent/JP2015500333A/ja active Pending
- 2012-12-13 AU AU2012354056A patent/AU2012354056B2/en active Active
- 2012-12-13 CN CN201280069595.5A patent/CN104114179A/zh active Pending
- 2012-12-13 CA CA3056570A patent/CA3056570C/en active Active
- 2012-12-13 ES ES12857932T patent/ES2831699T3/es active Active
- 2012-12-13 DK DK12857932.3T patent/DK2790710T3/da active
- 2012-12-13 CA CA2859122A patent/CA2859122C/en active Active
- 2012-12-13 US US14/364,992 patent/US10064890B2/en active Active
- 2012-12-13 CN CN201910013584.9A patent/CN109568338A/zh active Pending
- 2012-12-13 WO PCT/IL2012/050521 patent/WO2013088440A1/en not_active Ceased
- 2012-12-13 EP EP12857932.3A patent/EP2790710B1/en active Active
-
2014
- 2014-06-12 IL IL233107A patent/IL233107B/en active IP Right Grant
-
2017
- 2017-12-28 AU AU2017279824A patent/AU2017279824A1/en not_active Abandoned
-
2018
- 2018-05-08 JP JP2018089672A patent/JP2018138591A/ja active Pending
- 2018-07-31 US US16/050,651 patent/US10688124B2/en active Active
-
2019
- 2019-10-01 JP JP2019181138A patent/JP2019214631A/ja active Pending
-
2020
- 2020-01-31 AU AU2020200704A patent/AU2020200704A1/en not_active Abandoned
- 2020-05-18 IL IL274755A patent/IL274755B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017279824A1 (en) | 2018-01-25 |
| JP2018138591A (ja) | 2018-09-06 |
| IL233107B (en) | 2020-06-30 |
| AU2012354056A1 (en) | 2014-07-10 |
| EP2790710A1 (en) | 2014-10-22 |
| IL274755A (en) | 2020-07-30 |
| US20150056306A1 (en) | 2015-02-26 |
| AU2020200704A1 (en) | 2020-02-20 |
| US10064890B2 (en) | 2018-09-04 |
| JP2019214631A (ja) | 2019-12-19 |
| JP2015500333A (ja) | 2015-01-05 |
| CA2859122C (en) | 2019-11-05 |
| CA2859122A1 (en) | 2013-06-20 |
| US10688124B2 (en) | 2020-06-23 |
| AU2012354056B2 (en) | 2017-10-05 |
| EP2790710B1 (en) | 2020-08-26 |
| AU2012354056A8 (en) | 2017-10-12 |
| IL274755B (en) | 2021-04-29 |
| ES2831699T3 (es) | 2021-06-09 |
| WO2013088440A1 (en) | 2013-06-20 |
| US20190022133A1 (en) | 2019-01-24 |
| CA3056570C (en) | 2022-04-19 |
| EP2790710A4 (en) | 2015-11-11 |
| CN104114179A (zh) | 2014-10-22 |
| WO2013088440A8 (en) | 2013-08-01 |
| CA3056570A1 (en) | 2013-06-20 |
| CN109568338A (zh) | 2019-04-05 |
| IL233107A0 (en) | 2014-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274755B (en) | Amorphous calcium carbonate for the treatment of poor calcium absorption and metabolic bone diseases | |
| DK2987507T3 (da) | Fremgangsmåder til behandling af degenerative knogletilstande | |
| DK3321276T3 (da) | Fusionsproteiner til behandling af metaboliske lidelser | |
| FR2976783B1 (fr) | Materiel d'osteosynthese vertebrale | |
| DK2371766T3 (da) | Fremgangsmåde til at opnå præcipiteret calciumcarbonat | |
| DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
| FR2982764B1 (fr) | Implant rachidien intervertebral | |
| BR112014010164A2 (pt) | implante de tecido duro | |
| DK2555807T5 (da) | Skabelon-øceller og små øcelleklynger til behandling af diabetes | |
| DK3192520T3 (da) | Terapeutiske midler til reducering af niveauerne af parathyreoideahormon | |
| DK2840065T3 (da) | Fremgangsmåde til fremstilling af præcipiteret calciumcarbonat | |
| DK2766483T3 (da) | Fremgangsmåder og sammensætninger til screening for og behandling af udviklingsforstyrrelser | |
| EP2575686A4 (en) | ORTHOPEDIC IMPLANTS | |
| BR112013014943A2 (pt) | compostos úteis para o tratamento de aids | |
| DK2635282T3 (da) | Sammensætninger til behandling af myelofibrose | |
| DK2688557T3 (da) | Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed | |
| DK2750551T3 (da) | Ortopædisk stol til behandling og forebyggelse af rygmarvslidelser | |
| IL228030A0 (en) | Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia | |
| DK2451482T3 (da) | Kombinationsterapi til behandlingen af diabetes | |
| BR112013031676A2 (pt) | membro âncora para equipamento de osteossíntese vertebral | |
| DK2436342T3 (da) | Indretning til påføring af knoglesubstitutionsmateriale | |
| EP2713914A4 (en) | BONE WRIST | |
| DK2734212T3 (da) | Sammensætninger omfattende diclofenac til behandling af postoperativ smerte | |
| DK2550922T3 (da) | Tibiaimplantat til stramning af knæskalsledbåndene | |
| EP2953632A4 (en) | AMORPHIC CALCIUM CARBONATE FOR ACCELERATING BONE GROWTH |